Exponent (EXPO) Q4 2025 earnings review
Guidance Accelerates: Exponent Pivots to Growth
Exponent delivered a definitive pivot point in Q4. Despite facing a tough comparison against a 14-week quarter in the prior year, the company grew Net Revenues by 4.5% and expanded EBITDA margins by 160bps to 26.8%. The real story is the outlook: management guided for 'high-single digit' growth in FY26, a marked acceleration from the sluggish 3.5% growth in FY25. While the Environmental segment remains a drag (-5%), the core Engineering business is surging (+7%) even with one less operating week.
🐂 Bull Case
The Engineering & Scientific segment (85% of revenue) grew 7% YoY in Q4. Considering Q4 25 had 13 weeks vs. 14 weeks in Q4 24, the organic growth rate is effectively double-digit, driven by consumer electronics user research and utility risk management.
Operational discipline is paying off. EBITDA margin expanded to 26.8% in Q4 (up from 25.2% last year), and FY26 guidance calls for further expansion to ~27.8% (midpoint), signaling that headcount additions are being efficiently utilized.
🐻 Bear Case
The Environmental & Health segment fell 5% YoY in Q4. While management cited the 'one less week' impact, the Engineering segment grew 7% under the same conditions. This divergence suggests genuine demand softness in chemical regulatory work.
Despite revenue growth, Full Year 2025 Net Income fell to $106.0M (from $109.0M in FY24) and EPS dropped to $2.07. Rising tax rates (28.0% vs 26.0%) and lack of operational leverage on the bottom line remain issues.
⚖️ Verdict: 🟢
Bullish. The guidance shift from 'low-single' (FY25) to 'high-single' (FY26) represents a material change in trajectory. The company successfully navigated the '14th week' headwind in Q4 and is proving that the headcount investments made earlier in the year are converting into billable revenue.
Key Themes
Accelerating Revenue Trajectory
Management's guidance indicates a structural shift in demand. After a year of 'low single digit' growth (FY25 actual: +3.5%), the forecast for 'high single digits' in both Q1 and FY26 confirms that the hiring ramp-up (+4% headcount in 2025) is meeting real market demand, specifically in complex systems and AI safety.
Segment Divergence: Environmental Laggard
A sharp bifurcation has emerged. The Engineering segment proved immune to the 13-week vs 14-week headwind, growing 7%. Meanwhile, Environmental & Health dropped 5%. This segment (15% of rev) is failing to participate in the recovery seen elsewhere.
Utilization and Rate Realization
Q4 EBITDA margin jumped to 26.8% from 25.2%. Management noted improved utilization year-over-year. This confirms that the 'headcount gap' concern from early 2025 has been resolved—they added 4% to headcount and simultaneously improved margins, proving high billability of new hires.
Tax Rate Headwinds
Taxation is eating into the growth story. The consolidated tax rate jumped to 27.4% in Q4 (vs 24.7% prior) and 28.0% for FY25 (vs 26.0% prior). Share-based award tax impacts swung from a benefit in '24 to a negative impact in '25, accounting for the entire drop in FY Net Income.
Proactive Service Demand
A key shift in Q4 was growth driven by 'proactive services' specifically in consumer electronics (user research) and utilities (risk management). This balances the portfolio against 'reactive' dispute work and suggests clients are resuming R&D and infrastructure investment spend.
Other KPIs
Stable/Accelerating. Up 4.5% YoY. This beat is significant because it compares a 13-week quarter (2025) against a 14-week quarter (2024). Adjusted for the extra week in the prior year, the growth rate is likely in the low-teens.
Accelerating. Up significantly from 25.2% in 24Q4. This indicates strong pricing power and utilization management, defying the typical margin compression often seen when ramping up headcount.
Solid liquidity. Down from $258.9M a year ago, but reflects active capital deployment: $61.5M in dividends and $97.8M in share repurchases during FY25.
Reversing. Down from $2.11 in FY24. While operations improved, the tax rate increase (28% vs 26%) caused the bottom-line miss. Pre-tax income was virtually flat ($147.3M vs $147.4M).
Guidance
Accelerating. This is a major step up from the 'flat' growth seen in 25Q1 and 25Q2. It implies demand has normalized and the company is capturing share in AI and safety-critical markets.
Stable/Expanding. Midpoint of 28.0% compares favorably to the 27.3% margin reported in 25Q1. Implies continued operational leverage.
Accelerating. Compared to 3.5% growth in FY25, this guidance suggests management sees a multi-quarter tailwind. This is the strongest annual growth outlook in recent quarters.
Stable. The range brackets the FY25 actual result of 27.6%, suggesting margins have plateaued at a healthy level rather than expanding significantly further.
Key Questions
Environmental Segment Recovery
Environmental & Health revenues declined 5% in Q4 while Engineering surged 7%. Is this purely a timing/project lumpy issue, or are you seeing structural weakness in chemical regulatory demand?
Tax Rate Normalization
The tax rate jump to 28% dragged FY25 earnings down despite top-line growth. Should we model 28% as the permanent new baseline for FY26, or were there one-time negative impacts in Q4?
AI Revenue Sizing
You mention AI and advanced analytics as key drivers. Are these engagements large enough to move the needle on the 'High-Single Digit' guidance, or are they still experimental pilot programs?